Quarterly report pursuant to Section 13 or 15(d)

Convertible Bridge Loan (Detail Textuals)

v3.8.0.1
Convertible Bridge Loan (Detail Textuals) - USD ($)
1 Months Ended 3 Months Ended
Jan. 31, 2018
Jan. 19, 2018
Dec. 28, 2017
Mar. 31, 2018
Dec. 31, 2017
Short-term Debt [Line Items]          
Proceeds from Convertible debt issuance       $ 400,000  
Convertible debt         $ 235,000
Amortization of convertible debt discount       34,608  
Change in fair value of conversion rights of convertible debt       185,000  
Loss on extinguishment of debt       (590,392)  
Marked to market the conversion liabilities       180,000  
Bridge Loan | Secured Promissory Note and Security Agreement | Emerald Health Sciences Inc          
Short-term Debt [Line Items]          
Aggregate gross proceeds     $ 900,000 0  
Proceeds from Convertible debt issuance     500,000    
Funds received under the Secured Promissory Note   $ 400,000      
Initial conversion price   $ 0.10      
Convertible debt     $ 265,000    
Shares converted into common stock   9,000,000      
Increase in conversion liability $ 360,000        
Amortization of convertible debt discount $ 34,608        
Change in fair value of conversion rights of convertible debt       185,000  
Loss on extinguishment of debt       $ 590,392